| RRN3 |
Homo sapiens |
|
RRN3 is differentially expressed in 67 experiments [69 up/64 dn]: 16 organism parts: cerebellum [1 up/0 dn], "frontal cortex, primary motor cortex, Brodmann's Area 4" [0 up/1 dn], ...; 20 disease states: normal [1 up/4 dn], teratozoospermia [0 up/1 dn], ...; 20 cell types, 23 cell lines, 15 compound treatments and 12 other conditions. |
| A-270G1.2, RRN3, TIFIA |
|
C36E8.1 (Caenorhabditis elegans)
RRN3 (Saccharomyces cerevisiae)
Tif-IA (Drosophila melanogaster)
(Compare orthologs)
|
|
|
| RNA polymerase I specific transcription initiation factor RRN3 |
|
|
| RNA polymerase I transcription factor activity, nucleoplasm, regulation of transcription, transcription from RNA polymerase I promoter, transcription |
|
|
|
O75703
Q3MHU9
Q9NYV6
|
|
|
|
ENSG00000085721
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
None
|
Compound treatment |
|
|
FLAP
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
MDA-MB-231
|
Cell line |
|
|
MK886
|
Compound treatment |
|
|
Endothelial cell
|
Cell type |
|
|
Monocyte
|
Cell type |
|
|
Control
|
Compound treatment |
|
|
Cerebellum
|
Organism part |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
MCF7
|
Cell line |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Caudate nucleus
|
Organism part |
|
|
Hypericin incubated, not irrad...
|
Growth condition |
|
|
Hypericin incubated, irradiate...
|
Growth condition |
|
|
HPL1
|
Cell line |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
CD34+
|
Cell type |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
HaCaT
|
Cell line |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Breast carcinoma
|
Disease state |
|
|
N/a
|
Test result |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
Epithelial cell
|
Cell type |
|
|
Stromal cell
|
Cell type |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
BT-474
|
Cell line |
|
|
Not applicable
|
Histology |
|
|
Dermal fibroblast
|
Cell type |
|
|
SKMEL5
|
Cell line |
|
|
HeLa
|
Cell line |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|
|
Epilepsy
|
Disease state |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
Peripheral blood mononuclear c...
|
Cell type |
|
|
T cell
|
Cell type |
|
|
Fibroblast
|
Cell type |
|
|
Neutrophil
|
Cell type |
|
|
T47D
|
Cell line |
|
|
MDA468
|
Cell line |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
PC3
|
Cell line |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
Skin
|
Organism part |
|
|
Benign nevi
|
Disease state |
|
|
SsMCF7
|
Cell line |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
Trichostatin A
|
Compound treatment |
|
|
Granulocyte-colony stimulating...
|
Compound treatment |
|
|
Oligodendroglioma
|
Disease state |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
Native skin
|
Cell type |
|
|
Experimental malaria-infected
|
Disease state |
|
|
Mannitol
|
Compound treatment |
|
|
Blood
|
Organism part |
|
|
Tonsil
|
Organism part |
|
|
Primary gastric tumor
|
Organism part |
|
|
Kaposi's sarcoma
|
Disease state |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
Uninfected
|
Infection |
|
|
Keratinocyte
|
Cell type |
|
|
MCF10A
|
Cell line |
|
|
Ethanol
|
Vehicle |
|
|
Temporal lobe
|
Organism part |
|
|
5-aza-2'-deoxycytidine + trich...
|
Compound treatment |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Down syndrome
|
Disease state |
|
|
Hydrogen peroxide
|
Compound treatment |
|
|
DMSO
|
Vehicle |
|
|
Actinomycin D
|
Compound treatment |
|
|
Thymus
|
Organism part |
|
|
Symptomatic
|
Disease staging |
|
|
CD16+ dendritic cell
|
Cell type |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
MKN28
|
Cell line |
|
|
Atrioventricular node
|
Organism part |
|
|
Bone marrow
|
Organism part |
|
|
Umbilical cord
|
Organism part |
|
|
Adult
|
Developmental stage |
|
|
Infant
|
Developmental stage |
|
|
Grade II
|
Tumor grading |
|
|
Dimethyl sulfoxide
|
Compound treatment |
|
|
Testis
|
Organism part |
|
|
HL-60
|
Cell line |
|
|
HMT3522S1
|
Cell line |
|
|
T84
|
Cell line |
|
|
Caco-2
|
Cell line |
|
|
Primary
|
Disease staging |
|
|
Lymph node metastasis
|
Disease staging |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
Classic-KS, HIV-, nodular (lat...
|
Disease state |
|
|
Grade IV
|
Tumor grading |
|
|
Primary fibroblast
|
Cell type |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
Non-ischemic cardiomyopathy
|
Disease state |
|
|
Glioblastoma
|
Disease state |
|
|
Cystic change
|
Histology |
|
|
17-allylamino-geldanamycin
|
Compound treatment |
|
|
Malignant pleural mesothelioma
|
Disease state |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
Granulocyte
|
Cell type |
|
|
Treated malaria, natural infec...
|
Disease state |
|
|
|
|
|
Processing time: 0.082 secs.